CD44 binding to hyaluronic acid is redox regulated by a labile disulfide bond in the hyaluronic acid binding site

12Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

CD44 is the primary leukocyte cell surface receptor for hyaluronic acid (HA), a component of the extracellular matrix. Enzymatic post translational cleavage of labile disulfide bonds is a mechanism by which proteins are structurally regulated by imparting an allosteric change and altering activity. We have identified one such disulfide bond in CD44 formed by Cys77 and Cys97 that stabilises the HA binding groove. This bond is labile on the surface of leukocytes treated with chemical and enzymatic reducing agents. Analysis of CD44 crystal structures reveal the disulfide bond to be solvent accessible and in the-LH hook configuration characteristic of labile disulfide bonds. Kinetic trapping and binding experiments on CD44-Fc chimeric proteins show the bond is preferentially reduced over the other disulfide bonds in CD44 and reduction inhibits the CD44-HA interaction. Furthermore cells transfected with CD44 no longer adhere to HA coated surfaces after pre-treatment with reducing agents. The implications of CD44 redox regulation are discussed in the context of immune function, disease and therapeutic strategies.

Cite

CITATION STYLE

APA

Kellett-Clarke, H., Stegmann, M., Barclay, A. N., & Metcalfe, C. (2015). CD44 binding to hyaluronic acid is redox regulated by a labile disulfide bond in the hyaluronic acid binding site. PLoS ONE, 10(9). https://doi.org/10.1371/journal.pone.0138137

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free